Suchergebnisse - "Gay, Francesca"

PubPharm (232)

1

An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma

enthalten in: Nature immunology | 2024

von de Jong, M. | Fokkema, C. | Papazian, N. | +17

2

Belantamab mafodotin : an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma

enthalten in: Haematologica | 2024

von Mateos, M. | Weisel, K. | Terpos, E. | +13

3

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma

enthalten in: Blood | 2024

von D'Agostino, M. | Bertuglia, G. | Rota-Scalabrini, D. | +22

CommentIn: Blood. 2024 Feb 15;143(7):564-566. - PMID 38358852

4

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P. | Dimopoulos, M. | Boccadoro, M. | +141

CommentIn: N Engl J Med. 2024 Apr 18;390(15):1440. - PMID 38631009

5

Single-cell transcriptomic analysis of NK cell dynamics in myeloma patients reveal persistent reduction of cytotoxic NK cells from diagnosis to relapse

enthalten in: bioRxiv.org | 2023

von Tahri, S. | de Jong, M. | Fokkema, C. | +18

6

A rational approach to functional high-risk myeloma

enthalten in: Hematology. American Society of Hematology. Education Program | 2023

von Gay, F. | Bertuglia, G. | Mina, R.

7

Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129) : final analysis of a non-randomised, multicentre, phase 2 study

enthalten in: The Lancet. Oncology | 2023

von van de Donk, N. | Minnema, M. | van der Holt, B. | +25

8

Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice : A Modified Delphi Study

enthalten in: HemaSphere | 2023

von Ramasamy, K. | Avet-Loiseau, H. | Hveding Blimark, C. | +8

ErratumIn: Hemasphere. 2023 Nov 02;7(11):e986. - PMID 37928623

9

Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma

enthalten in: Experimental hematology & oncology | 2023

von Bandini, C. | Mereu, E. | Paradzik, T. | +18

10

Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma

enthalten in: Experimental hematology & oncology | 2023

von Bandini, C. | Mereu, E. | Paradzik, T. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]